GO:0120567 hydroxytrimethyllysine aldolase activity: Mechanism, Genes and Research Methods

Research-grade guide for scientists and biopharma professionals

Key Takeaways

GO:0120567 (hydroxytrimethyllysine aldolase activity, synonym HTMLA) is a molecular_function defined as the catalysis of the reaction: (3S)-3-hydroxy-N(6),N(6),N(6)-trimethyl-L-lysine = 4-(trimethylamino)butanal + glycine.
HTMLA is a key enzyme in the carnitine biosynthesis pathway, converting (3S)-3-hydroxy-N(6),N(6),N(6)-trimethyl-L-lysine to 4-(trimethylamino)butanal and glycine.
In humans and mice, the gene encoding HTMLA was recently identified through virtual screening and experimental validation, filling a long-standing gap in the carnitine biosynthesis pathway.
The complete carnitine biosynthesis pathway, including HTMLA activity, has been characterized in Candida albicans, providing a fungal model for studying this enzyme.
Defects in carnitine biosynthesis can lead to carnitine deficiency disorders, affecting fatty acid oxidation and energy metabolism.
Researchers study HTMLA using CRISPR knockout, point mutation, knock-in, and overexpression models, combined with metabolomics and enzyme assays [1,2].

Description

Hydroxytrimethyllysine aldolase activity (GO:0120567) is a molecular function that catalyzes the cleavage of (3S)-3-hydroxy-N(6),N(6),N(6)-trimethyl-L-lysine into 4-(trimethylamino)butanal and glycine. This reaction is a critical step in the carnitine biosynthesis pathway, which is essential for fatty acid transport into mitochondria and energy production. Despite its importance, the enzyme responsible for this activity in humans and mice was only recently identified through a combination of computational and experimental approaches. In the yeast Candida albicans, a complete carnitine biosynthesis pathway including this activity has been characterized, offering insights into the evolutionary conservation of the pathway. Understanding hydroxytrimethyllysine aldolase activity is therefore crucial for researchers studying carnitine metabolism, mitochondrial function, and related metabolic disorders.

hydroxytrimethyllysine aldolase activity At A Glance

GO ID GO:0120567
GO term hydroxytrimethyllysine aldolase activity
Ontology molecular_function
Synonym HTMLA
Definition Catalysis of the reaction: (3S)-3-hydroxy-N(6),N(6),N(6)-trimethyl-L-lysine = 4-(trimethylamino)butanal + glycine.
Major function Catalyzes a step in carnitine biosynthesis
Pathway Carnitine biosynthesis
Substrate (3S)-3-hydroxy-N(6),N(6),N(6)-trimethyl-L-lysine
Products 4-(trimethylamino)butanal and glycine

What Is GO:0120567?

Hydroxytrimethyllysine aldolase activity (GO:0120567) is defined as the catalysis of the reaction: (3S)-3-hydroxy-N(6),N(6),N(6)-trimethyl-L-lysine = 4-(trimethylamino)butanal + glycine. In other words, it is an aldolase that breaks down a trimethyllysine derivative into two products, one of which is a precursor for carnitine synthesis.

Why Is hydroxytrimethyllysine aldolase activity Important in Cell Biology?

Hydroxytrimethyllysine aldolase activity is essential for carnitine biosynthesis, a process required for the transport of long-chain fatty acids into mitochondria for beta-oxidation and energy production. Carnitine deficiency can lead to severe metabolic disorders, including cardiomyopathy, skeletal myopathy, and hypoglycemia. The recent identification of the gene encoding this activity in humans and mice has opened new avenues for studying carnitine-related diseases and for developing therapeutic strategies. Furthermore, the presence of this activity in Candida albicans highlights its importance in microbial metabolism and potential as an antifungal target.
Critical for carnitine biosynthesis and fatty acid oxidation.
Defects can cause carnitine deficiency disorders.
Provides a target for studying mitochondrial energy metabolism.
Conserved in fungi such as Candida albicans.
Enables metabolic engineering for carnitine production.
Potential role in diseases linked to impaired fatty acid oxidation.
Useful for understanding enzyme evolution and substrate specificity.
Can be studied using CRISPR-based gene editing [1,2].

Molecular Mechanism of hydroxytrimethyllysine aldolase activity

Substrate Recognition and Binding
In simple terms: The enzyme grabs its target molecule, a modified lysine, and holds it in place.
Hydroxytrimethyllysine aldolase specifically binds (3S)-3-hydroxy-N(6),N(6),N(6)-trimethyl-L-lysine, a trimethylated lysine derivative. This substrate is generated in the carnitine biosynthesis pathway. The enzyme's active site is tailored to accommodate this substrate, ensuring high specificity.
Catalytic Cleavage
In simple terms: The enzyme cuts the molecule into two pieces: a smaller one called glycine and a larger one that continues down the carnitine pathway.
The aldolase catalyzes the cleavage of the substrate into 4-(trimethylamino)butanal and glycine. This retro-aldol reaction likely involves the formation of a Schiff base intermediate with a catalytic lysine residue, although the exact mechanism remains to be fully elucidated.
Product Release and Pathway Continuation
In simple terms: The products are released, and the larger piece goes on to become carnitine.
After cleavage, 4-(trimethylamino)butanal is further processed by downstream enzymes to eventually form carnitine. Glycine is released as a byproduct. The efficient release of products is crucial for maintaining flux through the pathway.
Cofactors and Regulation
In simple terms: The enzyme might need helper molecules and can be turned on or off.
The cofactor requirements for hydroxytrimethyllysine aldolase are not fully defined, but similar aldolases often require pyridoxal phosphate. Regulation may occur at the transcriptional level or via substrate availability, as seen in other carnitine biosynthesis enzymes [1,2].

Key Genes Involved in GO:0120567 hydroxytrimethyllysine aldolase activity

The following genes and proteins are involved in hydroxytrimethyllysine aldolase activity and related carnitine biosynthesis pathways.
GeneMajor RoleResearch Relevance
HTMLA (human)Encodes hydroxytrimethyllysine aldolaseRecently identified; mutations may affect carnitine synthesis
HTMLA (mouse)Ortholog of human HTMLAModel for studying carnitine biosynthesis in vivo
Candida albicans homologCatalyzes same reaction in fungiFungal model for pathway analysis
TMLHTrimethyllysine hydroxylaseUpstream enzyme in carnitine biosynthesis
HTMLAHydroxytrimethyllysine aldolaseDirectly catalyzes the reaction
BBOX1Gamma-butyrobetaine hydroxylaseDownstream enzyme in carnitine biosynthesis
SLC25A20Carnitine-acylcarnitine translocaseTransports carnitine derivatives into mitochondria
CPT1ACarnitine palmitoyltransferase 1Rate-limiting for fatty acid oxidation
CPT2Carnitine palmitoyltransferase 2Mitochondrial beta-oxidation
ACADVLVery long-chain acyl-CoA dehydrogenaseFatty acid oxidation
HADHATrifunctional protein subunit alphaMitochondrial fatty acid oxidation
ETFAElectron transfer flavoprotein alphaFatty acid oxidation
SLC22A5Carnitine transporterCellular carnitine uptake
PPARαRegulator of lipid metabolismTranscriptional control of carnitine pathway
PGC-1αMitochondrial biogenesis regulatorMay influence carnitine biosynthesis
AMPKEnergy sensorRegulates fatty acid oxidation
mTORGrowth regulatorMay affect carnitine pathway

How Is hydroxytrimethyllysine aldolase activity Regulated?

The regulation of hydroxytrimethyllysine aldolase activity is not well characterized, but it is likely controlled at the transcriptional level in response to metabolic demands. In Candida albicans, the carnitine biosynthesis pathway is regulated by the availability of precursors and may be subject to feedback inhibition. In mammals, PPARα and PGC-1α are known to regulate genes involved in fatty acid oxidation and mitochondrial function, which could indirectly influence carnitine biosynthesis.

hydroxytrimethyllysine aldolase activity and Human Disease

GeneDisease / BiologyPotential Experimental Model
HTMLACarnitine deficiencyKnockout mouse, patient-derived cells
CPT2CPT2 deficiencyKnockout cell lines, patient fibroblasts
SLC22A5Primary carnitine deficiencyKnockout mice, iPSC-derived cardiomyocytes
Candida albicans homologFungal virulenceC. albicans knockout strains
BBOX1Carnitine biosynthesis defectKnockout models
Carnitine Deficiency Disorders
Deficiencies in carnitine biosynthesis, including impaired hydroxytrimethyllysine aldolase activity, can lead to primary carnitine deficiency, characterized by cardiomyopathy, skeletal myopathy, and hypoglycemia. The recent identification of the human HTMLA gene allows for genetic testing and potential therapeutic interventions.
Mitochondrial Fatty Acid Oxidation Defects
Reduced carnitine levels due to defective hydroxytrimethyllysine aldolase activity can impair mitochondrial fatty acid oxidation, leading to accumulation of toxic fatty acid intermediates and energy deficiency. This is particularly relevant in disorders such as CPT2 deficiency and VLCAD deficiency.
Fungal Pathogenesis
In Candida albicans, the carnitine biosynthesis pathway, including hydroxytrimethyllysine aldolase activity, is important for growth on non-fermentable carbon sources and may contribute to virulence. Targeting this enzyme could be a strategy for antifungal development.

From hydroxytrimethyllysine aldolase activity-Related Genes to Experimental Models

Research QuestionSuitable Model
Does HTMLA knockout reduce carnitine levels?CRISPR knockout in HepG2 or HEK293 cells
Does a point mutation in HTMLA affect enzyme activity?Point mutation knock-in in cell lines
Can HTMLA overexpression increase carnitine production?Overexpression in mammalian cells
Is HTMLA essential for Candida albicans growth?CRISPR knockout in C. albicans
What is the subcellular localization of HTMLA?Tagged knock-in with GFP
Does HTMLA interact with other carnitine biosynthesis enzymes?Co-immunoprecipitation in knockout background

How to Study the hydroxytrimethyllysine aldolase activity Process

MethodWhat It MeasuresTypical Application
Enzyme assayCatalytic activity of HTMLAKinetic studies, inhibitor testing
LC-MS metabolomicsCarnitine and intermediatesPathway flux analysis
CRISPR knockoutGene functionLoss-of-function studies
RNA-seqGene expressionTranscriptional regulation
Western blotProtein levelsValidation of knockout/overexpression
ImmunofluorescenceSubcellular localizationOrganelle targeting
Co-IPProtein interactionsComplex formation
Yeast complementationFunctional conservationHeterologous expression
Enzymatic Activity Assays
Direct measurement of hydroxytrimethyllysine aldolase activity using purified enzyme or cell lysates, monitoring the formation of 4-(trimethylamino)butanal or glycine by HPLC or mass spectrometry.
Metabolomics
Quantification of carnitine and its precursors in cells or tissues to assess pathway flux. This can reveal the impact of genetic perturbations on hydroxytrimethyllysine aldolase activity.
CRISPR Screening
Genome-wide knockout screens to identify genes that modulate carnitine levels or sensitivity to fatty acid oxidation inhibitors, potentially uncovering regulators of HTMLA.
Transcriptomics and Proteomics
RNA-seq and mass spectrometry to study expression changes in carnitine biosynthesis genes under different metabolic conditions [1,2].

How CRISPR Can Be Used to Study GO:0120567 hydroxytrimethyllysine aldolase activity

Knockout

CRISPR knockout of the HTMLA gene in human cell lines (e.g., HepG2) can abolish hydroxytrimethyllysine aldolase activity, leading to reduced carnitine levels and impaired fatty acid oxidation. This model is useful for studying the metabolic consequences of enzyme loss.

Point Mutation

Introducing specific point mutations in the HTMLA active site can help identify catalytic residues and understand the enzyme's mechanism. Such models can also mimic patient mutations if identified.

Knock-in

Knock-in of a tagged version of HTMLA (e.g., GFP or FLAG) allows for localization and interaction studies without affecting endogenous regulation. This is valuable for understanding the enzyme's role in the carnitine biosynthesis complex.

Overexpression

Overexpression of HTMLA in cells can increase carnitine production and may be used to study the effects of enhanced pathway flux on mitochondrial function and energy metabolism.

How EDITGENE Supports hydroxytrimethyllysine aldolase activity Research

Researchers studying hydroxytrimethyllysine aldolase activity-related genes often need to determine whether a candidate gene is causally involved in carnitine biosynthesis or related metabolic pathways. EDITGENE provides comprehensive CRISPR-based services to create precise cell models for such investigations.
Contact EDITGENE today to design your custom CRISPR model for hydroxytrimethyllysine aldolase activity research.

Frequently Asked Questions About hydroxytrimethyllysine aldolase activity

It is a molecular function (GO:0120567) that catalyzes the conversion of (3S)-3-hydroxy-N(6),N(6),N(6)-trimethyl-L-lysine to 4-(trimethylamino)butanal and glycine, a step in carnitine biosynthesis.
The gene encoding this activity was recently identified in humans and mice, and a homolog exists in Candida albicans [1,2].
It catalyzes the cleavage of a trimethyllysine derivative to produce a precursor for carnitine, which is essential for fatty acid transport into mitochondria.
Deficiency can lead to carnitine deficiency disorders, characterized by cardiomyopathy, skeletal myopathy, and hypoglycemia.
You can use enzymatic assays, metabolomics, and CRISPR knockout models to measure activity and pathway flux [1,2].
Yes, the activity has been found in humans, mice, and Candida albicans, indicating evolutionary conservation [1,2].
The substrate is (3S)-3-hydroxy-N(6),N(6),N(6)-trimethyl-L-lysine; the products are 4-(trimethylamino)butanal and glycine.
Enzyme assays coupled with HPLC or mass spectrometry are commonly used to detect product formation.
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models can be generated to study gene function.
The official definition is available in the Gene Ontology database (QuickGO) and is based on the catalytic reaction.

Conclusion

Hydroxytrimethyllysine aldolase activity (GO:0120567) is a critical enzymatic step in carnitine biosynthesis, with implications for mitochondrial fatty acid oxidation and metabolic health. The recent identification of the responsible gene in humans and mice has opened new research directions, while the fungal homolog provides a comparative model. Understanding this activity through CRISPR-based models and biochemical assays will advance our knowledge of carnitine-related disorders and potential therapeutic targets.

References

  1. 1. Malatesta M et al.. 2024. One substrate many enzymes virtual screening uncovers missing genes of carnitine biosynthesis in human and mouse.. Nat Commun 15(1):3199 PMID: 38615009
  2. 2. Strijbis K et al.. 2009. Identification and characterization of a complete carnitine biosynthesis pathway in Candida albicans.. FASEB J 23(8):2349-59 PMID: 19289605
Contact Us
*
*
*
*
How did you hear about us: